P25
Systematic comparative functional pan-genome analysis reveals epistasis- and pleiotropy-dependent evolutionary behaviors for polycyclic aromatic hydrocarbon metabolism in the genus Mycobacterium
Sunday, July 20, 2014
The genus Mycobacterium is of great interest for medical and biotechnological issues. In this study, we conducted a systematic comparative functional pan-genomic analysis to generate a useful mycobacterial compendium of phenotypic and genomic changes, focusing on the PAH-degrading phenotype with pan-genomic perspective of the evolutionary events, standing with the environmental challenges. Phylogenic, phenotypic, and genomic information of 27 complete genome-sequenced mycobacteria were systematically integrated to reconstruct a mycobacterial phenotype network (MPN) with pan genomic concept at network level. In the MPN, mycobacterial phenotypes show typical scale-free relationships. The PAH degradation is an isolated phenotype with the lowest connection degree, consistent with phylogenetic and environmental isolation of PAH-degraders. A series of functional pan-genomic analyses provided conserved/unique genomic evidences for strong epistatic and pleiotropic impacts on evolutionary trajectories of the PAH-degrading phenotype. Under strong natural selection, the detailed gene gain/loss patterns by HGT/deletion events hypothesize a plausible evolutionary path, an epistatic-based birth and pleiotropic-dependent death, for bacterial PAH metabolism in the genus Mycobacterium. Our findings suggest that when selection acts on evolution of PAH metabolism, only a very small fraction of trajectories is likely to be observed, owing mainly to combination of the double-faced phenotypic effects of PAHs and the corresponding pleiotropy- and epistasis-dependent evolutionary behaviors. Evolutionary constraints on the selective choice of trajectories like those seen in PAH-degrading phenotype are likely to apply to the evolution of other phenotypes in the genus Mycobacterium, which is essential to better characterizing mycobacterial communities associated with medical or bioengineering applications.